ARAVA

LOE Approaching

leflunomide

NDAORALTABLETPriority Review
Approved
Sep 1998
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
12

Mechanism of Action

(a mitochondrial enzyme involved in de novo pyrimidine synthesis) and has antiproliferative activity. Several in vivo and in vitro experimental models have demonstrated an anti-inflammatory effect.

Pharmacologic Class:

Antirheumatic Agent

Indications (1)

Clinical Trials (5)

NCT06714461N/AActive Not Recruiting

A Study of the Effectiveness of Additional Risk Minimization Measures Related to ARAVA® (Leflunomide) in Saudi Arabia

Started May 2025
3,500 enrolled
Rheumatoid ArthritisPsoriatic Arthritis
NCT02258230N/ACompleted

Laparoscopic Three-dimensional Versus Two-dimensional Sacral Colpopexy and Paravaginal Repair

Started Dec 2014
194 enrolled
Pelvic Organ ProlapseCystocele
NCT01342016Phase 3Terminated

A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients

Started Apr 2011
84 enrolled
Lupus Nephritis
NCT00596206Phase 3Completed

Leflunomide EfficAcy Response Related to Dosing Regimen in Early Rheumatoid Arthritis

Started Dec 2007
124 enrolled
Arthritis, Rheumatoid
NCT00280644Phase 4Completed

Leflunomide in Rheumatoid Arthritis

Started Apr 2004
60 enrolled
Arthritis, Rheumatoid